4.5950
+0.0850
+(1.88%)
As of 2:59:40 PM EDT. Market Open.
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
647,392
752,688
679,223
384,124
Total Liabilities Net Minority Interest
153,992
153,186
128,291
26,772
Total Equity Gross Minority Interest
493,400
599,502
550,932
357,352
Total Capitalization
493,400
599,502
550,932
357,352
Common Stock Equity
493,400
599,502
550,932
357,352
Capital Lease Obligations
69,983
74,907
81,918
1,955
Net Tangible Assets
493,400
599,502
550,932
357,352
Working Capital
499,842
600,943
528,064
345,104
Invested Capital
493,400
599,502
550,932
357,352
Tangible Book Value
493,400
599,502
550,932
357,352
Total Debt
69,983
74,907
81,918
1,955
Share Issued
88,758.2180
81,969.6930
61,730.8160
48,511.7350
Ordinary Shares Number
88,758.2180
81,969.6930
61,730.8160
48,511.7350
12/31/2021 - 6/17/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
THTX Theratechnologies Inc.
2.5505
-0.76%
MURA Mural Oncology plc
2.6900
+11.16%
THRD Third Harmonic Bio, Inc.
5.12
-0.19%
KTTA Pasithea Therapeutics Corp.
1.3800
+0.73%
CDT Conduit Pharmaceuticals Inc.
0.6471
-17.05%
BCTX BriaCell Therapeutics Corp.
4.4200
-1.34%
PHIO Phio Pharmaceuticals Corp.
2.7689
+2.56%
PRTG Portage Biotech Inc.
8.41
+24.78%
DWTX Dogwood Therapeutics, Inc.
4.4001
+17.97%
SKYE Skye Bioscience, Inc.
1.4450
-8.54%